So we wouldn't blame long term Fulgent Genetics, Inc. (NASDAQ:FLGT) shareholders for doubting their decision to hold, with the stock down 45% over a half decade. Now let's have a look at the company's ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback